Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 17 May 2022

Tuesday, 17 May 2022

Ceisteanna (650, 683)

Neasa Hourigan

Ceist:

650. Deputy Neasa Hourigan asked the Minister for Health his plans to make Kaftrio available to children with cystic fibrosis who have only one delta F508 mutation and as such have no other suitable modulator; and if he will make a statement on the matter. [24167/22]

Amharc ar fhreagra

Gary Gannon

Ceist:

683. Deputy Gary Gannon asked the Minister for Health if his attention has been drawn to the situation of 35 children with cystic fibrosis (details supplied) who are being denied access to the life-changing drug kaftrio; and if he will make a statement on the matter. [24368/22]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 650 and 683 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Barr
Roinn